AMD earnings beat as overall sales surge by 36%

AMD earnings beat as overall sales surge by 36%


Lisa Su, CEO of AMD, attends the Artificial Intelligence Action Summit at the Grand Palais in Paris, Feb. 10, 2025.

Benoit Tessier | Reuters

Advanced Micro Devices reported first fiscal quarter earnings on Tuesday that topped expectations, and provided a strong forecast for current quarter revenue.

Shares of AMD rose in extended trading more than 4%.

Here’s how the chipmaker did versus LSEG expectations for the quarter ending March 29:

  • Earnings per share: 96 cents adjusted vs. 94 cents expected
  • Revenue: $7.44 billion vs. $7.13 billion expected

For the current quarter, AMD expects about $7.4 billion in sales with a gross margin of 43% versus Wall Street estimates for earnings of 86 cents adjusted on $7.25 billion in sales.

AMD’s forecast also included $800 million in costs that the company said it would incur because the U.S. limited the export of some of the company’s artificial-intelligence chips during the quarter.

The company reported net income of $709 million, or 44 cents per diluted share, versus net income of $123 million, or 7 cents per share, during the year-earlier period. Revenue grew 36% on an annual basis.

AMD is the second-place server central processing unit vendor, behind Intel, but its Epyc line of processors has been taking market share in recent years.

The company is also the closest competitor to Nvidia for “big GPUs,” or graphics processing units. Those are the kind of chips that are deployed in data centers by the thousands for building and deploying generative AI. It did $5 billion in AI GPU sales in the company’s fiscal 2024.

Both are reported in the company’s data center segment, which came in at $3.7 billion in sales, topping a StreetAccount estimate. Data center sales were up 57% on an annual basis, which the company attributed to demand for both Epic processors as well as its Instinct GPUs.

The company’s other major segment, Client and Gaming, includes chips for consumer devices such as laptops, gaming PCs, and game consoles. The overall segment rose 28% on an annual basis to $2.9 billion. AMD said that sales for its laptop and PC chips, which it calls client revenue, surged 68% year-over-year because of strong demand for chips called Zen 5 the company released last summer.

Gaming sales, however, declined 30% on an annual basis, which the company attributed to a decrease in console chip revenue.

AMD’s embedded segment, which is mostly sales from the company’s 2022 acquisition of Xilinx, declined 3% on an annual basis to $823 million.

WATCH: Chip stocks fall as Nvidia, AMD warn of higher costs from China export controls

Chip stocks fall as Nvidia, AMD warn of higher costs from China export controls



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More